欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3900/004
药品名称Rivaroxaban Sandoz 2.5 mg
活性成分
    • RIVAROXABAN 2.5 mg
剂型Film-coated tablet
上市许可持有人Sandoz B.V. Hospitaaldreef 29 1315 RC Almere The Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Austria (AT)
    • Poland (PL)
    • Latvia (LV)
      Runaplax 2,5 mg apvalkotās tabletes
    • Lithuania (LT)
      Runaplax 2,5 mg plėvele dengtos tabletės
    • Estonia (EE)
      RUNAPLAX
    • Slovenia (SI)
许可日期2020/11/25
最近更新日期2024/08/22
药物ATC编码
    • B01AF01 rivaroxaban
申请类型
  • TypeLevel1:Line Extension
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase